Skip to content

Longitudinal associations of naturalistic psychedelic use with psychotic and manic symptoms.

Otto Simonsson, Simon B. Goldberg, Walter Osika, Cecilia U. D. Stenfors, Sankalp Chaturvedi, Caroline M. Swords, Jayanth Narayanan, Peter S. Hendricks

Psychol Med March 31, 2025 DOI: 10.1017/s0033291725000716 via PubMed Central

Summary

AI-generated from the abstract

In a large online survey of over 12,000 participants followed for two months, people who used psychedelics outside of medical supervision reported increases in psychotic and manic symptoms. These increases occurred only among those who used psychedelics in an illegal context. The severity of psychotic symptoms rose with more frequent use and more intense challenging experiences, while manic symptoms increased more in individuals with a history of schizophrenia or bipolar I disorder and those who reported a strong sense of insight during their psychedelic experience. The findings suggest that naturalistic psychedelic use in illegal settings may pose risks for certain individuals.

Study at a glance

Characteristics Observational cohort Longitudinal Peer reviewed
Sample size 12,345
Population Adults with self-reported naturalistic psychedelic use, including those with psychiatric histories of schizophrenia or bipolar I disorder
Duration 2-month study period
Topics Psilocybin
Keywords Psychedelics Mental health research Drug safety Psychiatric symptoms
Citations 16
Key finding Naturalistic psychedelic use in illegal contexts was associated with increases in psychotic and manic symptoms, moderated by frequency of use, challenging experiences, and psychiatric history.

Abstract

BACKGROUND: Findings from contemporary clinical trials suggest that psychedelics are generally safe and may be effective in the treatment of various psychiatric disorders. However, less is known about the risks associated with psychedelic use outside of medically supervised contexts, particularly in populations that are typically excluded from participation in clinical trials. METHODS: =21,990), we investigated associations between self-reported naturalistic psychedelic use and psychotic and manic symptoms, with emphasis on those with psychiatric histories of schizophrenia or bipolar I disorder. RESULTS: The follow-up survey was completed by 12,345 participants (56% retention), with 505 participants reporting psychedelic use during the 2-month study period. In covariate-adjusted regression models, psychedelic use during the study period was associated with increases in the severity of psychotic and manic symptoms. However, such increases were only observed for those who reported psychedelic use in an illegal context. While increases in the severity of psychotic symptoms appeared to depend on the frequency of use and the intensity of challenging psychedelic experiences, increases in the severity of manic symptoms appeared to be moderated by a personal history of schizophrenia or bipolar I disorder and the subjective experience of insight during a psychedelic experience. CONCLUSIONS: The findings suggest that naturalistic psychedelic use specifically in illegal contexts may lead to increases in the severity of psychotic and manic symptoms. Such increases may depend on the frequency of use, the acute subjective psychedelic experience, and psychiatric history.

Explore topics

Comments

No comments yet.

Log in to comment